TETRAPHASE PHARMACEUTICALS INC Contract with Customer, Asset, after Allowance for Credit Loss, Current
TETRAPHASE PHARMACEUTICALS INC had Contract with Customer, Asset, after Allowance for Credit Loss, Current of $3.00 million as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ContractWithCustomerAssetNetCurrent · last filed 2020-03-12
- 2019-03-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $3.00M.
- 2018-12-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $3.00M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss, Current |
|---|---|
| 2019-03-31 | $3.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $3.00M 10-K · filed 2020-03-12 |